Patents by Inventor Christina Juneau

Christina Juneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100272708
    Abstract: The present application relates to methods for the treatment of eczema and uses of a dairy-derived composition. The treatment involves oral administration of 800 mg/day of a composition comprising TGF-?1, TGF-?2, IGF-1 and 60% (w/w) beta-lactoglobulin derived from whey.
    Type: Application
    Filed: June 10, 2008
    Publication date: October 28, 2010
    Inventors: Christina Juneau, Rejean Drouin, Olivier Moroni
  • Patent number: 7763257
    Abstract: The present invention relates to a composition and methods or uses thereof in the prophylaxis and treatment of psoriasis and other auto-immune inflammatory disorders. The composition may be comprised of TGF-?1, TGF-?2, and dairy derived proteins comprising a large proportion of ?-lactoglobulin.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: July 27, 2010
    Inventors: Christina Juneau, Réjean Drouin, Yves Pouliot, Najat Aattouri, Sylvie Gauthier, Eric Lamiot
  • Publication number: 20100121037
    Abstract: The invention relates to the general field of protein fractionation, and more particularly to the selective fractionation of growth factor from dairy products, such as milk, whey and colostrum. There is provided methods for the selective fractionation of TGF-?, lactoferrin and bovine serum albumin.
    Type: Application
    Filed: April 1, 2008
    Publication date: May 13, 2010
    Applicant: UNIVERSITE LAVAL
    Inventors: David Lachkar, Yves Pouliot, Sylvie Gauthier, Sylvie Turgeon, Eric Lamiot, Christina Juneau
  • Publication number: 20100119614
    Abstract: The present invention relates to a process for the preparation of a composition used in the prophylaxis and treatment of psoriasis and other auto-immune inflammatory disorders. The composition may be comprised of TGF-?1, TGF-?2, and dairy derived proteins comprising a large proportion of -lactoglobulin.
    Type: Application
    Filed: April 2, 2008
    Publication date: May 13, 2010
    Inventors: Christina Juneau, Réjean Drouin, Olivier Moroni
  • Publication number: 20090074893
    Abstract: The invention provides a method for the prevention or treatment of virus infections comprising administering, to a human or animal individual susceptible to or suffering from a virus infection, an effective amount of one or more casein phosphopeptides (CPP). Also provided is a composition containing such casein peptides and further agents such as vitamin C and/or nutritional components for use in treating or preventing virus infections.
    Type: Application
    Filed: April 28, 2006
    Publication date: March 19, 2009
    Applicant: CAMPINA NEDERLAND HOLDING B.V.
    Inventors: Rick de Waard, Yves Pouliot, Christina Juneau, Leon Franciscus Mallee
  • Publication number: 20080031969
    Abstract: The present invention relates to a composition and methods or uses thereof in the prophylaxis and treatment of psoriasis and other auto-immune inflammatory disorders. The composition may be comprised of TGF-?1, TGF-?2, and dairy derived proteins comprising a large proportion of ?-lactoglobulin.
    Type: Application
    Filed: April 3, 2007
    Publication date: February 7, 2008
    Inventors: Christina Juneau, Rejean Drouin, Yves Pouliot, Najat Aattouri, Sylvie Gauthier, Eric Lamiot
  • Publication number: 20060127493
    Abstract: The present invention relates to a composition and methods or uses thereof in the prophylaxis and treatment of psoriasis and related disorders. The composition may be comprised of TGF-?l, TGF-?2, and a large proportion of dairy derived proteins.
    Type: Application
    Filed: December 9, 2004
    Publication date: June 15, 2006
    Inventors: Yves Pouliot, Sylvie Gauthier, Eric Lamiot, Najat Aattouri, Christina Juneau
  • Publication number: 20040081703
    Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumor, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a crude cartilage extract in an aqueous solution, this crude extract being fractionated to recover molecules of a molecular weight less than about 500 kDa. Some of the biologically active components of the extract are prepared by further fractionation. The cartilage extract can be used for treating diseases or conditions having etiological components selected from the group consisting of tumor proliferation, angiogenesis, inflammation, metalloprotease activity and collagenolysis. Several cosmetic applications based on the capacity of the liquid extract to improve skin conditions are also disclosed. A simple and efficient process for the preparation of cartilage extracts is also disclosed.
    Type: Application
    Filed: October 17, 2003
    Publication date: April 29, 2004
    Applicant: Les Laboratoires Aeterna, Inc.
    Inventors: Eric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus, Richard Beliveau
  • Patent number: 6635285
    Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumor, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a crude cartilage extract in an aqueous solution, this crude extract being fractionated to recover molecules of a molecular weight less than about 500 kDa. Some of the biologically active components of the extract are prepared by further fractionation. The cartilage extract can be used for treating diseases or conditions having etiological components selected from the group consisting of tumor proliferation, angiogenesis, inflammation, metalloprotease activity and collagenolysis. Several cosmetic applications based on the capacity of the liquid extract to improve skin conditions are also disclosed. A simple and efficient process for the preparation of cartilage extracts is also disclosed.
    Type: Grant
    Filed: February 7, 2002
    Date of Patent: October 21, 2003
    Assignee: Les Laboratoires Aeterna, Inc.
    Inventors: Éric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus, Richard Béliveau
  • Publication number: 20030013858
    Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumor, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a crude cartilage extract in an aqueous solution, this crude extract being fractionated to recover molecules of a molecular weight less than about 500 kDa. Some of the biologically active components of the extract are prepared by further fractionation. The cartilage extract can be used for treating diseases or conditions having etiological components selected from the group consisting of tumor proliferation, angiogenesis, inflammation, metalloprotease activity and collagenolysis. Several cosmetic applications based on the capacity of the liquid extract to improve skin conditions are also disclosed. A simple and efficient process for the preparation of cartilage extracts is also disclosed.
    Type: Application
    Filed: February 7, 2002
    Publication date: January 16, 2003
    Applicant: AEeterna Laboratories, Inc.
    Inventors: Eric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus, Richard Beliveau
  • Patent number: 6380366
    Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumor, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a crude cartilage extract in an aqueous solution, this crude extract being fractionated to recover molecules of a molecular weight less than about 500 kDa. Some of the biologically active components of the extract are prepared by further fractionation. The cartilage extract can be used for treating diseases or conditions having etiological components selected from the group consisting of tumor proliferation, angiogenesis, inflammation, metalloprotease activity and collagenolysis. Several cosmetic applications based on the capacity of the liquid extract to improve skin conditions are also disclosed. A simple and efficient process for the preparation of cartilage extracts is also disclosed.
    Type: Grant
    Filed: February 15, 2000
    Date of Patent: April 30, 2002
    Assignee: Les Laboratoires Aeterna Inc.
    Inventors: Éric Dupont, Paul Brazeau, Christina Juneau, Richard Béliveau
  • Patent number: 6028118
    Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumoral, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being separated in a solid fraction (SOLID EXTRACT) and a liquid fraction which was further fractionated to obtain a LIQUID EXTRACT having molecules of a molecular weight comprised between 0 to 500 kDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components.
    Type: Grant
    Filed: August 8, 1996
    Date of Patent: February 22, 2000
    Assignee: Les Laboratoires Aeterna Inc.
    Inventors: Eric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus
  • Patent number: 6025334
    Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, direct anti-tumor proliferating, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being centrifuged and further fractionated to obtain a total extract having molecules of a molecular weight comprised between 0 to 500 KDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components. Due to the multiplicity of biological activities of the total liquid extract, it can be used for treating numerous diseases or conditions such as those having components selected from the group consisting of tumor proliferation, angiogenesis, inflammation and collagenolysis.
    Type: Grant
    Filed: October 30, 1995
    Date of Patent: February 15, 2000
    Assignee: Les Laboratoires Aeterna Inc.
    Inventors: Eric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus